MMR
MMR is a biological therapy with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Booster Dose of sIPV Co-administered With MMR and HepA-I.
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers
Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR
Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)
Clinical Trials (9)
Booster Dose of sIPV Co-administered With MMR and HepA-I.
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers
Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR
Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)
Homeopathic Vaccine Trial
Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants
A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months
All 9 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 9